Seeing Is Believing
Currently out of the existing stock ratings of Joy Zhang, 6 are a BUY (46.15%), 6 are a HOLD (46.15%), 1 are a SELL (7.69%).
Analyst Joy Zhang, currently employed at LEERINK, carries an average stock price target met ratio of 42% that have a potential upside of 7.79% achieved within 157 days. Previously, Joy Zhang worked at GOLDMAN SACHS.
Joy Zhang’s has documented 26 price targets and ratings displayed on 5 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on HIMS, Hims Hers Health at 09-May-2023.
Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for HIMS (HIMS HERS HEALTH) at 8/9/2022. The price target of $5 was fulfilled within 62 days with a profit of $1.33 (21.01%) receiving and performance score of 3.39.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-May-2026
$7.5
$-1.61 (-17.67%)
$6.5
1 months 27 days ago
(05-Aug-2026)
19/26 (73.08%)
$-0.51 (-6.37%)
70
Hold Since 13-Nov-2025
$6
$-3.11 (-34.14%)
$9
4 months 20 days ago
(12-May-2026)
2/2 (100%)
$0.91 (17.88%)
16
Hold Since 12-May-2026
$8
$-1.11 (-12.18%)
$10
4 months 20 days ago
(12-May-2026)
1/3 (33.33%)
$2.91 (57.17%)
78
Hold Since 14-Dec-2022
$6
$-3.11 (-34.14%)
$12
4 months 20 days ago
(12-May-2026)
8/10 (80%)
$0.91 (17.88%)
24
Hold Since 03-Jul-2025
$10
$0.89 (9.77%)
$12
4 months 20 days ago
(12-May-2026)
0/3 (0%)
$4.91 (96.46%)
What Year was the first public recommendation made by Joy Zhang?